ライフサイエンスコーパス: pseudocyst

1 pase normalized along with resolution of the pseudocyst.

2 sm was performed after the resorption of the pseudocyst.

3 c MR finding for the diagnosis of pancreatic pseudocyst.

4 ific proteins and a formation of subpodocyte pseudocyst.

5 ean interval of 42.7 days after diagnosis of pseudocyst.

6 normalities that can be seen with pancreatic pseudocyst.

7 ccess of percutaneous drainage of pancreatic pseudocyst.

8 pancreatitis (MPD > 7 mm) and an associated pseudocyst.

9 , late bacteriologic changes, abscesses, and pseudocysts.

10 ta for differentiating cystic neoplasms from pseudocysts.

11 -KO mouse myocardium contained more parasite pseudocysts.

12 nflammation, necrosis, fibrosis, and T cruzi pseudocysts.

13 l stay than surgical treatment of pancreatic pseudocysts.

14 pancreas developed in 22 patients (1.8%): 12 pseudocysts, 2 cysts/remnants, 4 intraductal papillary m

15 neoplasm (15%), chronic pancreatitis (14%), pseudocyst (3%), and trauma (3%).

16 isease (4 patients), 2) localized abscess or pseudocyst (6 patients), or 3) severe disease (11 patien

17 18%), neuroendocrine tumor (14%), pancreatic pseudocyst (6%), cystadenocarcinoma (3%), and miscellane

18 vere acute ischemic pancreatitis, pancreatic pseudocyst, abdominal aortic aneurysm, generalized ather

19 ical ventilation, 109 (26%) of 422 developed pseudocysts, acute insulin therapy was needed in 81 (21%

20 ter 19 weeks with no evidence of a recurrent pseudocyst and a normal serum amylase level.

21 astric mass include hepatomegaly, pancreatic pseudocyst and epigastric hernia, less common causes bei

22 tients who underwent operative management of pseudocyst and fluid collections as their sole mode of i

23 ur report focuses on these complications and pseudocysts and on the surgical management.

24 Pancreatic pseudocysts and peripancreatic fluid collections associa

25 Although many cysts, such as pseudocysts and serous cystadenomas, are benign and can

26 c fluid collections include hematoma/seroma, pseudocyst, and abscess.

27 as and three inflammatory), one had a benign pseudocyst, and one had abundant inflammatory cells on R

28 s, two peripancreatic fluid collections, one pseudocyst, and one intra-abdominal abscess; two donors

29 4 (9.4%) were acute collections, 178 (49.3%) pseudocysts, and 149 (41.3%) walled-off necrosis (WON).

30 o have debris by either or both readers were pseudocysts, and only one (4%) of the 22 cystic neoplasm

31 s of subchondral bone thickness, subchondral pseudocysts, and osteophytes.

32 creatic fluid collections are referred to as pseudocysts; and acute necrotic collections, as walled-o

33 Pancreatic pseudocysts are a common complication of pancreatitis, a

34 Pancreatic pseudocysts are collections of inflammatory fluid associ

35 Radiologically, pseudocysts are drained externally using a percutaneous,

36 Although most pseudocysts are not symptomatic and many resolve spontan

37 surgery in cases of pancreatic necrosis and pseudocyst assessed.

38 ocrine drainage who developed a large pelvic pseudocyst associated with a dilated pancreatic duct and

39 ning ductal anatomy when managing pancreatic pseudocysts associated with chronic pancreatitis.

40 ectrum of histology, including inflammatory (pseudocysts), benign (serous), premalignant (mucinous),

41 s between the gastrointestinal tract and the pseudocyst cavity.

42 Profound edema or formation of a pseudocyst containing plasma proteins is a prominent cha

43 The percutaneous pseudocyst-cystostomy obviated the need for surgical rev

44 nitive treatment at the time of laparoscopy (pseudocyst debridement, ovarian cyst excision).

45 In seven patients with pseudocysts, debris was seen in two (28%) at MR imaging

46 However, patients with pseudocyst disease alone did better than other groups.

47 Pseudocyst disease is associated with the best outcome,

48 hese 103 patients, 56 underwent combined LPJ/pseudocyst drainage and 47 had LPJ alone.

49 ng therapeutic procedures such as endoscopic pseudocyst drainage and fine needle injection to treat p

50 Hemorrhagic complications during EUS-guided pseudocyst drainage can occur, because the vessels on th

51 lve or persist beyond 6 weeks, at which time pseudocyst drainage can safely be combined with cholecys

52 ed with either combined simultaneous LPJ and pseudocyst drainage or with LPJ alone.

53 that cannot be removed with use of standard pseudocyst drainage techniques.

54 rial bleeding precipitated during EUS-guided pseudocyst drainage which stopped instantaneously by pla

55 and surgical cystogastrostomy for pancreatic pseudocyst drainage, none of the patients in the endosco

56 Compared to combined LPJ/pseudocyst drainage, the patients undergoing LPJ alone h

57 circulation near the pseudocyst wall during pseudocyst drainage, the placement of an expandable meta

58 and surgical cystogastrostomy for pancreatic pseudocyst drainage.

59 c fluid collections or pseudocysts until the pseudocysts either resolve or persist beyond 6 weeks, at

60 rly cholecystectomy group required operative pseudocyst-enterostomy.

61 Data on demographics, clinical presentation, pseudocyst etiology and characteristics, diagnostic eval

62 aracterized by intense edema or formation of pseudocysts filled with plasma proteins, mainly albumin.

63 rrent methods for the drainage of pancreatic pseudocysts, focusing on the recent developments in the

64 ith progression to pancreatic calcification, pseudocyst formation, endocrine and exocrine insufficien

65 ch as pancreatic abscess and intrapancreatic pseudocyst have been abandoned.

66 Two hundred fifty-three patients with pseudocyst have been evaluated.

67 stectomy as well as management of pancreatic pseudocysts have been reported.

68 ded pancreatic necrosis, pancreatic abscess, pseudocyst, hemorrhagic pancreatitis, and pancreatic asc

69 fy septa within cystic neoplasms than within pseudocysts; however, the difference was not significant

70 ipancreatic fluid collections and subsequent pseudocyst in outcomes after cholecystectomy in these pa

71 SDOCT showed hyporeflective retinal pseudocysts in 13.6% of eyes.

72 nefit of percutaneous drainage of pancreatic pseudocysts in unselected patients has not been realized

73 nage versus surgical treatment of pancreatic pseudocysts in unselected patients.

74 s of pancreatitis (eg, infected necrosis and pseudocysts) in particular subsets of patients.

75 sts, nonoperative interventions performed on pseudocysts, intercurrent episodes of acute pancreatitis

76 Simultaneous drainage of pseudocyst is not necessary.

77 resolve spontaneously over time, drainage of pseudocysts is occasionally required.

78 hey are often misdiagnosed as non-neoplastic pseudocysts leading to failed opportunities for curative

79 c distortion of the fovea, which may include pseudocysts, macular schisis, cystoid macular edema, and

80 orrelation with the failure and successes of pseudocysts managed by percutaneous drainage as well as

81 creatitis, and recent data suggest that many pseudocysts may be observed or treated successfully by p

82 ause the vessels on the internal wall of the pseudocyst might be compressed by the fluid and thus not

83 lasms (n=15), serous cystadenomas (n=12), or pseudocysts (n=9), with confirmation of histologic diagn

84 holecystectomy, resolution or persistence of pseudocysts, nonoperative interventions performed on pse

85 dominal pain were associated with having had pseudocysts (odds ratio [OR] 9.48 [95% CI 3.01-35.49], p

86 ions of the pancreas and a caudal pancreatic pseudocyst of 39x24 mm.

87 ent fluid collections, three abscesses, four pseudocysts, one hematoma, and one small-bowel and Roux-

88 esions (four endothelial cysts, three benign pseudocysts, one nonspecific benign cyst, one carcinoma,

89 ree methods for the drainage of a pancreatic pseudocyst, only the endoscopic approach can provide min

90 was defined as persistence of a symptomatic pseudocyst or the need for additional intervention other

91 of surgically correctable complications (eg, pseudocysts or biliary obstruction).

92 ed mechanical ventilation, need for insulin, pseudocysts, or death was associated with older age (med

93 The primary end point was pseudocyst recurrence after a 24-month follow-up period.

94 e of the patients in the endoscopy group had pseudocyst recurrence during the follow-up period, there

95 ng-term pain relief was achieved in 90%, and pseudocyst recurrence was less than 1%.

96 tients who received endoscopic therapy had a pseudocyst recurrence, compared with 1 patient treated s

97 Of 20 patients with pancreatic pseudocysts, seven had pseudocysts that were identified

98 ent for peripancreatic fluid collections and pseudocysts should be made with careful assessment of th

99 Mean pseudocyst size was 4.2 +/- 1 cm, 8.2 +/- 1.1 cm, and 7.

100 macular hole stages, beginning with a foveal pseudocyst (stage 1A) and typically followed by disrupti

101 ients with pancreatic pseudocysts, seven had pseudocysts that were identified at pathologic resection

102 a with conventional percutaneous drainage, a pseudocyst-to-bladder drainage was performed.

103 Patients with pancreatic pseudocysts underwent endoscopic (n = 20) or surgical cy

104 onstrate peripancreatic fluid collections or pseudocysts until the pseudocysts either resolve or pers

105 tandard technique for drainage of pancreatic pseudocysts, use of endoscopic methods is increasing.

106 leeding from collateral circulation near the pseudocyst wall during pseudocyst drainage, the placemen

107 s of patients with a diagnosis of pancreatic pseudocyst was performed from 1984 to 1995.

108 The pancreatic pseudocyst was resorbed in eight months.

109 Patients with a diagnosis of pancreatic pseudocyst were evaluated from 1985 to 2000.

110 reatitis and/or pathologic confirmation of a pseudocyst were excluded.

111 The six patients with localized abscess or pseudocyst were successfully treated with standard opera

112 Most pseudocysts were managed by percutaneous drainage, and a

113 ice with peripancreatic fluid collections or pseudocysts were monitored.

114 tibiotics; abscess formation was reduced and pseudocysts were smaller and less frequently infected.

115 ollow-up of 12 months, 1 patient developed a pseudocyst, which was successfully drained endoscopicall

116 Beginning in 1985, all patients with pseudocyst who were candidates for intervention (operati

117 patients with pancreatic cystic neoplasms or pseudocysts who underwent pancreatic MR imaging.

118 m benign cystic lesions (serous cystadenomas+pseudocysts) with a 78% sensitivity at 80% specificity,

119 Various modalities are currently applied to pseudocysts, with little or no data to aid in the choice

120 lated morphology in cystic neoplasms than in pseudocysts, with the difference between these lesion ty